Back to User profile » Dr Chaitra Ujjani
Papers published by Dr Chaitra Ujjani:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of Tazemetostat
Raychaudhuri R, Ujjani C
OncoTargets and Therapy 2022, 15:193-199
Published Date: 27 February 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
Ujjani C, Mato A, Hill BT, Allan JN, Lansigan E, Jacobs R, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M
Blood and Lymphatic Cancer: Targets and Therapy 2020, 10:1-5
Published Date: 24 August 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Lai C, Kandahari AM, Ujjani C
Blood and Lymphatic Cancer: Targets and Therapy 2019, 9:63-71
Published Date: 9 December 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Primary effusion lymphoma: current perspectives
Narkhede M, Arora S, Ujjani C
OncoTargets and Therapy 2018, 11:3747-3754
Published Date: 28 June 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The clinical development of obinutuzumab for the treatment of follicular lymphoma
Ma B, Ujjani C
Cancer Management and Research 2017, 9:103-113
Published Date: 10 April 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The expanding role of bendamustine in chronic lymphocytic leukemia
Nair KS, Ujjani C
Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:65-74
Published Date: 8 July 2015